BONESUPPORT Signs Strategic Agreement with MTF Biologics

BONESUPPORT signed an agreement with MTF Biologics, gaining U.S. rights to demineralized bone matrices that complement CERAMENT bone void filler and Collagen Matrix bone graft substitute products.

BONESUPPORT will sell the MTF products under its own brand and through its own U.S. distribution network.

In May 2018, BONESUPPORT announced its...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us